{"id":"W2342132516","doi":"10.1200/jco.2009.27.15_suppl.1083","title":"Phase II study of sagopilone (ZK-Epo) in patients with recurrent metastatic breast cancer (MBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Progressive disease; Internal medicine; Clinical endpoint; Adverse effect; Anthracycline; Performance status; Breast cancer; Stage (stratigraphy); Cancer; Surgery; Phases of clinical research; Oncology; Gastroenterology; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757237,0.0009246278,0.001235303,0.0002980957,0.0002181813,0.0004697364,0.0004224249,0.0006030501,0.002388489],"category_scores_gemma":[0.0004986062,0.0003439878,0.0005962492,0.0002813181,0.0004473502,0.0003208478,0.0002423504,0.001261701,0.0006893435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005863436,"about_ca_system_score_gemma":0.0008201513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206016,"about_ca_topic_score_gemma":0.002198673,"domain_scores_codex":[0.9997793,0.0001001643,0.00001330911,0.00003286493,0.00002762695,0.00004665229],"domain_scores_gemma":[0.9997204,0.00003897051,0.00005472047,0.00002224243,0.00002020645,0.000143471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5806909,0.06479005,0.03478466,0.001123827,0.001527017,0.0008041626,0.0007088207,0.004069024,0.1164054,0.0002785902,0.005284941,0.1895327],"study_design_scores_gemma":[0.3079978,0.6214676,0.0582152,0.0000294506,0.0004811683,0.0007418419,0.00008392263,0.001574342,0.005691451,0.00009882301,0.003593081,0.00002532648],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971002,0.0008949026,0.0001728576,0.0001300152,0.00002264587,0.0007406755,0.0003347204,0.0000402997,0.0005636193],"genre_scores_gemma":[0.996067,0.0007110356,0.0005153667,0.0002065976,0.00006267251,0.0006541159,0.0008569164,0.00001070974,0.0009155965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002388489,"threshold_uncertainty_score":0.007990241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1398992369236602,"score_gpt":0.5438389371707747,"score_spread":0.4039397002471145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}